TP53 and cancer: Consistent with our observations of T253I both in the cancer tissue and cultured cells, many loss-of-function p53 mutations are known to result in high cellular levels of the mutant p53 protein because of impaired p53-induced MDM2 induction and reduced autoregulatory feedback [34].